Dr Reddy’s Laboratories: Global pharmaceutical company, India
Global pharmaceutical and drug development company from India, 

operating in over 100 countries worldwide.
  Quick Links
   Company News Coverage
   Sustainability Report
   NCE Pipeline
   Our Values
 
A convenient
                 digital info kit
  Press Kit >> Five years at a glance
 
Based on consolidated U.S.GAAP financials
 
All Figures In Rs. Million Except EPS
YEAR ENDING MARCH 31, 2006
2006
2005
2004
2003
2002
INCOME STATEMENT DATA
Product Sales
24,077
19,126
20,081
18,070
16,409
Service Income
142
47
22
-
-
License Fees
48
346
-
-
125
Other
-
-
-
-
89
Total Revenues
24,267
19,519
20,104
18,070
16,623
Cost of Revenues
12,417
9,386
9,337
7,848
6,869
Gross Profit
11,850
10,134
10767
10222
9754
as a % of revenues
49
52
54
57
59
OPERATING EXPENSES
Seeling, general and administrative expenses
8029
6774
6543
5103
3674
Research and Development expenses
2153
2803
1992
1412
742
Amortization expenses
420
350
383
419
488
Foreign Exchange (gain/ Loss )
126
489
(282)
70
(209)
Other Operating (income)/ expenses, net
320
6
83
-
-
TOTAL OPERATING EXPENSES
10408
10422
8718
7004
4695
Operating Income
1442
(289)
2049
3218
5059
asa % of revenues
6
(1)
10
18
30
Equity in loss of affiliate
(88)
(58)
(44)
(92)
(131)
Other (expense)/ income, net
534
454
536
683
154
INCOME BEFORE INCOME TAX AND MINORITY INTEREST
1887
107
2540
3809
5083
Income tax benefit (expense)
(258)
94
(69)
(398)
(154)
Minority Interest
(0)
10
3
(7)
(15)
NET INCOME/ (LOSS)
1629
211
2474
3404
4914
as a % of revenues
7
1
12
19
30
Net income/ (loss) per equity share - basic
21.28
2.76
32.34
44.49
64.63
Net income/ (loss) per equity share - diluted
21.24
2.76
32.32
44.49
64.53
Dividednd declared per share of Rs.5 (Rs.)
5.00
5.00
5.00
5.00
7.50
BALANCE SHEET DATA
Cash and cash equivalents
3713
9288
4376
7273
5109
Working Capital
1345
10771
11103
12024
9519
Total Assets
68768
29288
26619
23092
18967
Total long term debt, exculding current portion
20937
25
31
41
47
Total stockholders' equity
22272
20953
21039
18832
15457
ADDITIONAL DATA
Net cash provided by/ (used in)
Operating activities
1643
2292
3999
4367
4653
Investing activities
(34524)
633
(6506)
(1955)
(1533)
Financing activities
27211
1931
(376)
(153)
1422
Effect of exchange rate changes on cash
95
55
(14)
(95)
89
Expenditure on property, plant and equipment
(1873)
(1749)
(2416)
(1516)
(1090)
     
Source: Annual Report 2005-06  
Designed by Bodhtree IT Consulting Services
© 2001 - 2008 Dr. Reddy's Laboratories Ltd. All rights reserved
Site best viewed at 800x600 resolution